Although this was an exploratory analysis, the findings suggest that vitamin D may be associated with increased prostate cancer risk among men with higher IGF-2, and possibly other IGF analytes, in the absence of finasteride treatment. The gene discussed is IGF2; the disease is prostate carcinoma.